Vical (VICL - Get Report) researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. This stock is trading up 8.4% to $3.61 in recent trading.
Today's Range: $3.30-$3.61
52-Week Range: $2.61-$4.74Volume: 469,000 Three-Month Average Volume: 604,982 From a technical perspective, VICL is soaring higher here back above its 200-day moving average of $3.35 with decent volume. This move is quickly pushing VICL within range of triggering a near-term breakout trade. That trade will hit if VICL manages to take out some near-term overhead resistance levels at $3.69 to $3.93 with high volume. Traders should now look for long-biased trades in VICL as long as it's trending above its 200-day at $3.35, and then once it sustains a move or close above those breakout levels with volume that hits near or above 604,982 shares. If that breakout hits soon, then VICL will set up to re-test or possibly take out its next major overhead resistance levels at $4.40 to $4.74. Any move above $4.74 would then push VICL into new 52-week high territory, which is bullish technical price action. Delcath Systems Delcath Systems (DCTH - Get Report) is a development stage, specialty pharmaceutical and medical device company focused on oncology, initially cancers in the liver. This stock is trading up 8.4% to $1.54 in recent trading. Today's Range: $1.40-$1.55 52-Week Range: $1.01-$4.74 Volume: 3.25 million Three-Month Average Volume: 1.02 million From a technical perspective, DCTH is ripping higher here right above its 50-day moving average of $1.35 with monster upside volume. This stock has been uptrending for the last month, with shares moving higher from its recent low of $1.16 to its intraday high of $1.55. During that move, shares of DCTH have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed DCTH within range of triggering a near-term breakout trade. That trade will hit if DCTH manages to clear some near-term overhead resistance at $1.67 with high volume.